Predictive Oncology Inc.
POAI
$0.95
$0.000.00%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 34.92% | 42.09% | 37.57% | -- | 18.91% |
| Total Depreciation and Amortization | 9.66% | 8.92% | 10.75% | -- | -13.77% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -236.81% | 844.23% | -106.38% | -- | 74.30% |
| Change in Net Operating Assets | -47.94% | 61.38% | -56.31% | -- | -875.62% |
| Cash from Operations | -3.28% | 77.86% | 30.30% | -- | 9.97% |
| Capital Expenditure | -- | -- | -100.00% | -- | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 100.00% | -- | 100.00% | -- | -75.68% |
| Cash from Investing | 100.00% | 20,933.33% | -100.00% | -- | 97.49% |
| Total Debt Issued | -4.03% | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -78.32% | -- | -- |
| Issuance of Common Stock | -84.14% | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 78.55% | -- | -- | -- | -- |
| Cash from Financing | -78.36% | 2,323.93% | -75.92% | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2,030.78% | 167.06% | 26.43% | -- | 103.51% |